skip to main content

Health Care

DEA Removes In-Person Examination Requirement for Prescribing Controlled Substances Amid COVID-19 Public Health Emergency

Health care practitioners with valid DEA registrations may prescribe controlled substances via telemedicine while COVID-19 is considered a public health emergency. Generally, a provider may not issue a controlled substance prescription without an in-person medical examination; however, this…

Read More

1135 Waiver Response TO COVID-19

With Secretary Azar’s Public Health Emergency declaration and President Trump’s National Emergency declaration, CMS is authorized to grant Social Security Act §1135 waivers of Medicare, Medicaid or SCHIP requirements (“1135 Waivers”) with respect to COVID-19.  Such Waivers may be granted as (A)…

Read More

State Medicaid Programs Respond to Coronavirus

With the spread of the coronavirus (COVID-19), and tri-fold spread of fear relating to the same, State agencies have begun to take action with respect to care relating to coronavirus.  Specifically, State Medicaid programs across the nation are beginning to review both cost-sharing policies, such as…

Read More

Genetic Information under HIPAA

Genetic Information  is quickly becoming an important part of our lives. The Health Insurance Portability and Accountability Act of 1996,[1] as amended, and the final Privacy Rule[2] (HIPAA) are implicated by a healthcare provider’s or benefit plan’s creation, storage, and use of Genetic…

Read More